NASDAQ:CELC
Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results
Celcuity’s stock price skyrocketed on October 20, 2025 after the Minneapolis-based biotech reported game-changing clinical trial results. Shares jumped from around $52 to as high as $78–$81 intradaymarketbeat.com, an approximately 40–50% single-day leap, before…
Company hubNASDAQ:CELC
Celcuity (CELC) Stock News & Analysis
Follow the latest Celcuity (CELC) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
All coverage